Lipoxin A4 Inhibited the Activation of Hepatic Stellate Cells -T6 Cells by Modulating Profibrotic Cytokines and NF-κB Signaling Pathway.
Ting Zhang,Hua Hao,Zi-Qin Zhou,Tao Zeng,Jia-Min Zhang,Xiao-Yan Zhou
DOI: https://doi.org/10.1016/j.prostaglandins.2019.106380
IF: 3.813
2020-01-01
Prostaglandins & Other Lipid Mediators
Abstract:Background: The deposition of extracellular matrix (ECM) during hepatic fibrosis is an intermediate process in the progression of multiple chronic liver diseases to cirrhosis. Because activated hepatic stellate cells (HSCs) are the main source of ECM, HSCs activation is the central link in the formation of liver fibrosis. It was reported that the analogs of lipoxin A(4) (LXA(4)) had anti-fibrotic effects, but the mechanisms are still not clear. This study was conducted to explore the possible mechanisms involved in the process of LXA(4)-mediated inhibition of HSCs activation. Methods: Rat HSC-T6 cells were activated by LPS and treated with LXA(4) and/or BOC-2. The levels of ECM were assessed by hydroxyproline (Hyp) kit. The protein levels of alpha-SMA, Collagen I and III, MMP-2, MMP-9, TGF-beta 1, PDGF A and B, NF-kappa B P65, phosphorylated NF-kappa B P65 (P-P65) and NE-kappa B inhibitor alpha (I-kappa B alpha) were measured via western blot. The mRNA levels of MMP-2 and MMP-9 were observed by real-time PCR. The contents of TGF-beta 1 and PDGF were assessed by ELISA kits. Nuclear transfer assay kit was used to assess the activation and translation of NF-kappa B P65. Results: (1) LPS activated HSC-T6 cells and up-regulated alpha-SMA, but LXA(4) decreased LPS-induced alpha-SMA in HSC-T6 cells. (2) LXA(4) inhibited LPS-induced Hyp production, meanwhile down-regulated LPS-induced Collagen I, Collagen III, MMP-2, and MMP-9 in HSC-T6 cells. (3) LXA(4) decreased LPS-induced TGF-beta 1 and PDGF in HSC-T6 cells. (4) LXA(4) repressed LPS-activated NE-kappa B signaling pathway, causing a reduction of I-kappa B alpha degradation, NF-kappa B phosphorylation, and NF-kappa B p65 transposition in HSC-T6 cells. (4) BOC-2, the blocker of LOCA(4) receptor, inhibited all the effects of LXA(4). Conclusion: LXA(4) inhibited HSCs activation through down-regulation TGF-beta 1/PDGF, and repression NF-kappa B signal pathway.